Literature DB >> 11845128

Discordance between dipyridamole stress Tc-99m sestamibi SPECT and coronary angiography in patients with Kawasaki disease.

Yun-Ching Fu1, Chia-Hung Kao, Betau Hwang, Sheng-Ling Jan, Ching-Shiang Chi.   

Abstract

BACKGROUND: Kawasaki disease is an acute vasculitis syndrome of unknown etiology that mainly affects the coronary arteries. The purpose of this study was to assess the agreement between dipyridamole stress technetium 99m sestamibi single photon emission computed tomography (SPECT) and coronary angiography in these patients. METHODS AND
RESULTS: Forty-one consecutive patients (29 boys and 12 girls) who underwent coronary angiography were studied prospectively. Their ages at onset of the disease ranged from 2 months to 4.8 years (mean +/- SD, 1.9 +/- 1.3 years). Their ages at the time of the study ranged from 8 months to 15.3 years (6.2 +/- 4.4 years). The duration between symptom onset and the study ranged from 2 months to 12 years (4.3 +/- 4.0 years). All patients underwent dipyridamole stress Tc-99m sestamibi SPECT within 1 month of their angiographic studies. They were divided into 3 groups according to coronary angiography findings. Group A consisted of 2 patients (1 boy and 1 girl, aged 10.3 and 1.9 years, respectively) with coronary stenoses who also had aneurysms. Group B consisted of 10 patients (8 boys and 2 girls, aged 0.7-15.3 years [mean, 3.8 years]) with coronary aneurysms. Group C consisted of 29 patients (20 boys and 9 girls, aged 1.2-13.8 years [mean, 7 years]) with normal coronary angiograms. Two patients in group A (100%), 3 of 10 patients in group B (30%), and 19 of 29 patients in group C (65.5%) had myocardial perfusion defects. There was poor agreement between Tc-99m sestamibi SPECT and coronary angiography for detecting coronary stenoses (kappa = 0.07; P =.222) and aneurysms (kappa = -0.184; P =.158).
CONCLUSION: Significant discordance exists between Tc-99m sestamibi SPECT and coronary angiography in patients with Kawasaki disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11845128     DOI: 10.1067/mnc.2002.118238

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  16 in total

1.  Diagnostic accuracy of dipyridamole technetium 99m-labeled sestamibi myocardial tomography for detection of coronary artery disease.

Authors:  D D Miller; L T Younis; B R Chaitman; H Stratmann
Journal:  J Nucl Cardiol       Date:  1997 Jan-Feb       Impact factor: 5.952

Review 2.  Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome).

Authors:  B H Landing; E J Larson
Journal:  Am J Cardiovasc Pathol       Date:  1987

3.  Comparison of 201Tl SPET and treadmill exercise testing in patients with Kawasaki disease.

Authors:  S L Jan; B Hwang; Y C Fu; P C Lee; C H Kao; R S Liu; C S Chi
Journal:  Nucl Med Commun       Date:  2000-05       Impact factor: 1.690

4.  Detection of coronary artery stenosis in children with Kawasaki disease. Usefulness of pharmacologic stress 201Tl myocardial tomography.

Authors:  C Kondo; M Hiroe; T Nakanishi; A Takao
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

5.  Accuracy of dipyridamole SPECT imaging in identifying individual coronary stenoses and multivessel disease in women versus men.

Authors:  M I Travin; M S Katz; A W Moulton; N J Miele; B L Sharaf; L L Johnson
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

6.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

7.  Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents.

Authors:  S M Paridon; F M Galioto; J A Vincent; T L Tomassoni; N M Sullivan; J T Bricker
Journal:  J Am Coll Cardiol       Date:  1995-05       Impact factor: 24.094

8.  Tomographic myocardial perfusion scintigraphy in children with Kawasaki disease.

Authors:  R P Spielmann; C A Nienaber; G Hausdorf; R Montz
Journal:  J Nucl Med       Date:  1987-12       Impact factor: 10.057

9.  Pathology of the heart in Kawasaki disease.

Authors:  H Fujiwara; Y Hamashima
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

10.  Cardiac biopsy of Kawasaki disease.

Authors:  C Yutani; S Go; T Kamiya; O Hirose; H Misawa; H Maeda; T Kozuka; S Onishi
Journal:  Arch Pathol Lab Med       Date:  1981-09       Impact factor: 5.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.